Heron Therapeutics, Inc. /De/

UBS Group AG HRTX
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
2,997,073
Value ($000)
1,280
Weight
0.0%
2019 Q4 - 2026 Q2 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).